4.7 Article

Comparative Genomic Analysis of Esophageal Adenocarcinoma and Squamous Cell Carcinoma

期刊

CANCER DISCOVERY
卷 2, 期 10, 页码 899-905

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-12-0189

关键词

-

类别

资金

  1. NIH [RC2DE020957, CA57345, CA121113, CA146799, CA133012, DK087454]
  2. AACR Stand Up To Cancer Dream Team Translational Cancer Research Grant, the Virginia
  3. D.K. Ludwig Fund for Cancer Research
  4. China 863 High-Tech Key Projects [2012AA02A503, 2012AA02A209, 2012AA02A201]
  5. Innovation Scientists and Technicians Troop Construction Projects of Henan Province, China [3047]

向作者/读者索取更多资源

Esophageal cancer ranks sixth in cancer death. To explore its genetic origins, we conducted exomic sequencing on 11 esophageal adenocarcinomas (EAC) and 12 esophageal squamous cell carcinomas (ESCC) from the United States. Interestingly, inactivating mutations of NOTCH1 were identified in 21% of ESCCs but not in EACs. There was a substantial disparity in the spectrum of mutations, with more indels in ESCCs, A:T>C:G transversions in EACs, and C:G>G:C transversions in ESCCs (P < 0.0001). Notably, NOTCH1 mutations were more frequent in North American ESCCs (11 of 53 cases) than in ESCCs from China (1 of 48 cases). A parallel analysis found that most mutations in EACs were already present in matched Barrett esophagus. These discoveries highlight key genetic differences between EACs and ESCCs and between American and Chinese ESCCs, and suggest that NOTCH1 is a tumor suppressor gene in the esophagus. Finally, we provide a genetic basis for the evolution of EACs from Barrett esophagus.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据